Pharmacyclics is getting a priority review of its blood cancer treatment by federal regulators. A priority review shortens a drug evaluation by the Food and Drug Administration from 10 months to six. The acceptance of the application triggers a $75 million milestone payment to Pharmacyclics from Johnson & Johnson's Janssen unit.
Endo Health Solutions said Wednesday it will buy Boca Pharmacal for $225 million in a deal that expands its generic drug business. Boca Pharmacal says it makes "niche" generic drugs. Endo said privately-held Boca focuses on products that require special handling or administration.
Akorn Inc. plans to pay $640 million in cash to buy fellow generic drugmaker Hi-Tech Pharmacal Co. Inc. in a deal that it expects will help boost its adjusted earnings immediately. Lake Forest, Ill.-based Akorn said that it will pay $43.50 for each share of Amityville, N.Y.-based Hi-Tech. That represents a premium of more than 23 percent over Hi-Tech's closing price Monday of $35.21.
California pharmacists would be allowed to dispense substitute medications that are biologically similar to brand-name treatments under a bill that cleared the state Assembly on Monday. Biological medicines, which are created from living cells rather than by mixing chemicals, have been used to treat cancer and immune-system disorders.
Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and add to its pipeline of new drugs. Amgen Inc. said Sunday it will acquire Onyx for $125 per share, and it expects to complete the deal at the beginning of the fourth quarter.
Thousands of surgical mesh lawsuits have been filed nationwide. Only one other has gone to trial. Last week, a federal jury awarded a Georgia woman $2 million in her lawsuit against C.R. Bard. The lawsuits accuse the pelvic repair products' manufacturers of inadequate testing, failing to disclose potential risks and fraudulently promoting the mesh as a safe medical device.
Medafor makes Arista MPH Hemostat, a hemostatic agent that helps stop bleeding. C.R. Bard said Monday that the market for surgical hemostats is worth more than $1.4 billion. It expects the acquisition to add about 1 percent to overall revenue growth in 2014.
St. Jude Medical Inc. plans to pay up to $331 million to buy the Swiss maker of a catheter that can tell doctors whether the correct amount of force is being applied to the heart wall during a procedure to fix a form of irregular heartbeat.
When people have a brain injury so severe that they can't squeeze a loved one's hand or otherwise respond, there are few good ways to tell if they have any lingering awareness or are in a vegetative state. Now researchers have created a tool to peek inside the brain and measure varying levels of consciousness.
Medtronic Inc. said Monday that it closed its $200 million acquisition of Cardiocom, which develops and provides services that help manage chronic diseases. The Minneapolis-based medical device maker said it doesn't expect the deal to affect its fiscal year 2014 profit.
The jury had awarded Stryker $70 million and Jonker tripled that amount to $210 million because Zimmer willfully infringed on three patents held by Stryker. Jonker also said Stryker is entitled to $7.2 million in additional damages, $11.7 million in interest and ordered Zimmer to pay Stryker's attorney's fees.
As a child, Christina Stephens filled her parents' basement with Lego castles and pirate ships. When she put her Lego-building skills to work last month making a prosthetic leg out of the children's toy, she became an Internet sensation.
Standards have the power to turbo-charge innovation and fuel business growth. From design and manufacturing to distribution and marketing, all products and services are affected at some point by standardization. But standards and conformance also impact the strength of the American workforce.
Founder George Hepburn says he owed BB&T Bank $10 million on a line of credit. He told employees in a letter that he had to temporarily lay off about 70 percent of the workforce after the bank used $1 million he had earmarked for payroll to pay down his debt.
Since it broke out in China in March, the bird flu strain has infected more than 130 people and killed 43. Researchers say that genetically engineering this virus in the lab could help track whether it's changing in the wild to become a bigger threat.
A Chinese researcher was sentenced Tuesday to time served plus two years of probation on charges stemming from the theft of a research drug from a Wisconsin medical school. Hua Jun Zhao, 41, had pleaded guilty in July to a reduced charge of illegally downloading research data from the Medical College of Wisconsin, where he worked as a researcher.
The ruling by a Shanghai court expands use of the vaguely worded, 5-year-old anti-monopoly law and raises the possibility of action against other foreign companies. It comes amid Chinese investigations of possible bribery, price-fixing and other misconduct by global suppliers of milk, pharmaceuticals and other products.
The FDA said Wednesday that the strips are contaminated with a chemical used in the manufacturing process, which interferes with readings. FDA regulators are working with the company to investigate the problem and make sure it is corrected.
Many blame a system in which the country's hospitals nearly all are state-run but get too little money from Beijing. Most of China's 2.3 million doctors are hospital employees and are barred from adding to their income by taking on second jobs.
A prominent hacker who discovered a way to have automatic teller machines spit out cash and was set to deliver a talk about hacking pacemakers and other wireless implantable medical devices has died in San Francisco, authorities and his employer said.
More than a year after Japan's Supreme Court ordered camera and medical-equipment maker Olympus to stop punishing a whistleblower and reinstate him to his regular job, Masaharu Hamada is still fighting his courtroom battle. On Monday, he got company.
Panasonic Corp. said Friday it will sell its ultrasonic diagnostic equipment business to Konica Minolta Inc. in January 2014 as part of efforts to improve its financial base eroded by the firm's recent sluggish performance. Panasonic will sell the business operated by its health care subsidiary Panasonic Healthcare Co.
Since the whole purpose of the mechanism is to give those confined to a wheelchair greater mobility, the engineers sought a practical, yet empathetic approach to the design process. They wanted to create a device that was durable, yet lightweight. It was important to make the end product intuitive enough for people to use with ease and comfort.
A federal indictment unsealed Wednesday accuses former ArthroCare Corp. chief executive Michael Baker and former ArthroCare finance chief Michael Gluk of conspiracy, 11 counts of wire fraud and two of securities fraud. Baker also is charged with three counts of making false statements.
Researchers have developed a drug delivery technique for diabetes treatment in which a sponge-like material surrounds an insulin core. The sponge expands and contracts in response to blood sugar levels to release insulin as needed. The technique could also be used for targeted drug delivery to cancer cells.